Trademark: 86890989
Word
GENEFORGE
Status
Registered
Status Code
700
Status Date
Tuesday, May 1, 2018
Serial Number
86890989
Registration Number
5456122
Registration Date
Tuesday, May 1, 2018
Mark Type
4000
Filing Date
Friday, January 29, 2016
Published for Opposition
Tuesday, February 13, 2018

Trademark Owner History
Oxford Nanopore Technologies Limited - Original Registrant

Classifications
9 Apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICs (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis for scientific or research purposes; scientific apparatus and instruments for sequencing DNA, RNA, protein and polynucleic acid sequencing; scientific apparatus and laboratory devices for the scientific analysis of polynucleic acid sequences; apparatus and instruments for the analysis of nucleic and polynucleic acids for scientific or research purposes;apparatus and instruments for the analysis of nucleic and polynucleic acids, namely, microarrays, and silicon chip based arrays for scientific or research purposes; apparatus and instruments for analysis of genetic information, genomic information and proteomic information, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICS (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis for scientific or research purposes; Computer software programs, computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; scientific apparatus, devices and instruments for synthesising chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides for scientific research and scientific testing purposes; data processing apparatus, devices and instruments; scientific apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides for scientific research and scientific testing purposes; portable computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; computer peripheral devices; electronic display interfaces for the display of information obtained from scientific equipment; silicon chips; DNA chips; microarray chips; analyte detector chips for scientific or research use; biosensor chips for scientific or research use; apparatus and instruments for use in laboratory analysis, namely, empty cartridges for test samples, namely, cartridges for use with concentrates and solutions in solid or liquid form samples for scientific or research testing use; batteries; rechargeable batteries; chargers for batteries; computer docking stations; reaction units containing chemical or biological reagents, namely, reaction systems for scientific or research purposes; scientific testing apparatus, namely, Nanopore sensing devices; parts and fittings for all the aforesaid goods
5 Buffer solutions for medical or veterinary purposes; aqueous solvents for medical or veterinary purposes; non-aqueous solvents for medical or veterinary purposes; surfactants for medical and veterinary testing purposes; silicone oils for use in tests for medical and veterinary testing purposes; protein arrays for use in tests for medical or veterinary diagnosis purposes; all of the aforesaid for the analysis, synthesis and sequencing of nucleic acid polymers; none of the foregoing including enzymes for the production of biofuels and other products from renewable carbon feedstocks or enzymes for the conversion of cellulosic biomass to sugars and other products
1 Deoxyribonucleic acid, single stranded and double stranded deoxyribonucleic acid; ribonucleic acid; peptide nucleic acids; nucleic acids; oligonucleotides; peptides for industrial purposes and scientific research purposes; nucleotides, pyrimidines, purines for use in analytical tests for scientific and research purposes; chemicals for scientific or research use in tests to detect diseases in plant life, other than pesticides; buffer solutions for use in analytical chemistry, biochemistry, biology, biotechnology and genomic experiments and tests; aqueous solvents for scientific and research use; non-aqueous solvents for scientific and research use; silicone oils for use in analytical tests for scientific or research use; silicone fluids; all the aforesaid other than for medical or veterinary purposes; all of the aforesaid for the analysis, synthesis and sequencing of nucleic acid polymers; none of the foregoing including enzymes for the production of biofuels and other products from renewable carbon feedstocks or enzymes for the conversion of cellulosic biomass to sugars and other products
10 Medical and veterinary diagnostic apparatus and instruments for the testing and analysis of DNA, RNA and other genetic material for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; blood testing apparatus; diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; cartridges for test samples, for medical purposes; reaction units containing chemical reagents, namely, reaction systems for medical testing purposes; Nanopore sensing devices for medical or veterinary purposes; parts and fittings for all the aforesaid goods
42 Scientific and technological services and research and design relating thereto, namely, consultation, research and design services relating to automated systems and instruments for direct electrical detection and analysis of molecules for use in the field of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; industrial research services in the fields of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; scientific research in the fields of biology, chemistry, biochemistry, bacteriology, medicine and veterinary science; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular analysis services namely, biological, chemical, biochemical, bacteriological DNA, RNA, protein, polynucleic acid and molecular analysis for scientific testing and scientific research purposes; scientific and technological services, namely, synthesizing chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides for scientific purposes and medical research purposes; scientific research for medical or veterinary purposes; DNA and RNA and polynucleic acid sequencing services for scientific research purposes; protein sequencing services for scientific research purposes; design and development of instruments and apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; DNA and polynucleic acid testing services, namely, the analysis of DNA and polynucleic acids for scientific and scientific research purposes; genome sequencing services for scientific testing and scientific research purposes; information and advice regarding all the aforesaid services
GENE FORGE

Trademark Events
May 1, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 1, 2018
Registered-Principal Register
Feb 13, 2018
Official Gazette Publication Confirmation E-Mailed
Feb 13, 2018
Published For Opposition
Jan 24, 2018
Notification Of Notice Of Publication E-Mailed
Jan 6, 2018
Approved For Pub - Principal Register
Dec 22, 2017
Teas/Email Correspondence Entered
Dec 22, 2017
Correspondence Received In Law Office
Dec 21, 2017
Teas Request For Reconsideration Received
Jul 6, 2017
Notification Of Final Refusal Emailed
Jul 6, 2017
Final Refusal E-Mailed
Jul 6, 2017
Final Refusal Written
Jun 6, 2017
Teas/Email Correspondence Entered
Jun 5, 2017
Correspondence Received In Law Office
Jun 5, 2017
Teas Response To Office Action Received
Dec 30, 2016
Notification Of Non-Final Action E-Mailed
Dec 30, 2016
Non-Final Action E-Mailed
Dec 30, 2016
Non-Final Action Written
Dec 9, 2016
Teas/Email Correspondence Entered
Dec 9, 2016
Correspondence Received In Law Office
Dec 9, 2016
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 8, 2016
Assigned To Lie
Nov 22, 2016
Teas Response To Office Action Received
Jun 13, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 13, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 23, 2016
Notification Of Non-Final Action E-Mailed
May 23, 2016
Non-Final Action E-Mailed
May 23, 2016
Non-Final Action Written
May 16, 2016
Assigned To Examiner
Feb 9, 2016
Teas Amendment Entered Before Attorney Assigned
Feb 9, 2016
Teas Voluntary Amendment Received
Feb 4, 2016
Notice Of Pseudo Mark E-Mailed
Feb 3, 2016
New Application Office Supplied Data Entered
Feb 2, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24